{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:08:19Z","timestamp":1788174499114,"version":"build-2803163510"},"reference-count":11,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,1,14]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>Baseline maximum tumor diameter is an important predictor of relapse for patients with ES-HL achieving complete metabolic remission. Patients with baseline tumor size \u22655 cm have worse outcomes with ABVD alone and are likely to benefit from consolidation radiotherapy.<\/jats:p>","DOI":"10.1182\/bloodadvances.2019001023","type":"journal-article","created":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T11:41:30Z","timestamp":1579002090000},"page":"203-206","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":25,"title":["Maximum tumor diameter is associated with event-free survival in PET-negative patients with stage I\/IIA Hodgkin lymphoma"],"prefix":"10.1182","volume":"4","author":[{"given":"Tim M.","family":"Illidge","sequence":"first","affiliation":[{"name":"Division of Cancer Sciences, University of Manchester, National Institutes of Health Research Biomedical Research Centre Manchester Cancer Research Centre, Manchester, United Kingdom;"},{"name":"Christie NHS Foundation Trust, Manchester, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9316-7544","authenticated-orcid":false,"given":"Elizabeth H.","family":"Phillips","sequence":"additional","affiliation":[{"name":"Cancer Research UK and UCL Cancer Trials Centre, University College London, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Counsell","sequence":"additional","affiliation":[{"name":"Cancer Research UK and UCL Cancer Trials Centre, University College London, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Pettengell","sequence":"additional","affiliation":[{"name":"Haemato-oncology, St George's, University of London, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2306-4974","authenticated-orcid":false,"given":"Peter W. M.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Cancer Research UK Centre, University of Southampton, Southampton, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic J.","family":"Culligan","sequence":"additional","affiliation":[{"name":"Haematology, Aberdeen Royal Infirmary, Aberdeen, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilyana","family":"Popova","sequence":"additional","affiliation":[{"name":"Cancer Research UK and UCL Cancer Trials Centre, University College London, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Clifton-Hadley","sequence":"additional","affiliation":[{"name":"Cancer Research UK and UCL Cancer Trials Centre, University College London, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"McMillan","sequence":"additional","affiliation":[{"name":"Haematology, Nottingham City Hospitals NHS Trust, Nottingham, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8323-9567","authenticated-orcid":false,"given":"Peter","family":"Hoskin","sequence":"additional","affiliation":[{"name":"Division of Cancer Sciences, University of Manchester, National Institutes of Health Research Biomedical Research Centre Manchester Cancer Research Centre, Manchester, United Kingdom;"},{"name":"Christie NHS Foundation Trust, Manchester, United Kingdom;"},{"name":"Clinical Oncology, Mount Vernon Hospital, Middlesex, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2516-5288","authenticated-orcid":false,"given":"Sally F.","family":"Barrington","sequence":"additional","affiliation":[{"name":"King's College London and Guy's and St Thomas' PET Centre, School of Biomedical Engineering and Imaging Sciences, Kings College London, King's Health Partners, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7898-2786","authenticated-orcid":false,"given":"John","family":"Radford","sequence":"additional","affiliation":[{"name":"Division of Cancer Sciences, University of Manchester, National Institutes of Health Research Biomedical Research Centre Manchester Cancer Research Centre, Manchester, United Kingdom;"},{"name":"Christie NHS Foundation Trust, Manchester, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2020,1,14]]},"reference":[{"issue":"20","key":"2020011411395412000_B1","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1200\/JCO.18.01799","article-title":"Positron emission tomography score has greater prognostic significance than pretreatment risk stratification in early-stage Hodgkin lymphoma in the UK RAPID Study","volume":"37","author":"Barrington","year":"2019","journal-title":"J Clin Oncol"},{"issue":"13","key":"2020011411395412000_B2","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1182\/blood-2017-07-795476","article-title":"Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial","volume":"131","author":"Cottereau","year":"2018","journal-title":"Blood"},{"issue":"17","key":"2020011411395412000_B3","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1056\/NEJMoa1408648","article-title":"Results of a trial of PET-directed therapy for early-stage Hodgkin\u2019s lymphoma","volume":"372","author":"Radford","year":"2015","journal-title":"N Engl J Med"},{"issue":"16","key":"2020011411395412000_B4","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1200\/JCO.2016.68.6394","article-title":"Early positron emission tomography response-adapted treatment in stage I and II Hodgkin lymphoma: final results of the randomized EORTC\/LYSA\/FIL H10 trial","volume":"35","author":"Andr\u00e9","year":"2017","journal-title":"J Clin Oncol"},{"key":"2020011411395412000_B5","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood-2018-99-114519","article-title":"PET-guided treatment of early-stage favorable Hodgkin lymphoma: final results of the international, randomized phase 3 trial HD16 by the German Hodgkin Study Group","volume":"132","author":"Fuchs","year":"2018","journal-title":"Blood"},{"issue":"11","key":"2020011411395412000_B7","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","article-title":"Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin\u2019s disease: Cotswolds meeting","volume":"7","author":"Lister","year":"1989","journal-title":"J Clin Oncol"},{"issue":"10","key":"2020011411395412000_B8","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3324\/haematol.2016.141846","article-title":"Definition of bulky disease in early stage Hodgkin lymphoma in computed tomography era: prognostic significance of measurements in the coronal and transverse planes","volume":"101","author":"Kumar","year":"2016","journal-title":"Haematologica"},{"issue":"12","key":"2020011411395412000_B9","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1093\/annonc\/mdt413","article-title":"Impact of risk factors on outcomes in early-stage Hodgkin\u2019s lymphoma: an analysis of international staging definitions","volume":"24","author":"Klimm","year":"2013","journal-title":"Ann Oncol"},{"issue":"6","key":"2020011411395412000_B10","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/annonc\/mdx072","article-title":"Risk factors and a prognostic score for survival after autologous stem-cell transplantation for relapsed or refractory Hodgkin lymphoma","volume":"28","author":"Br\u00f6ckelmann","year":"2017","journal-title":"Ann Oncol"},{"issue":"27","key":"2020011411395412000_B11","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"issue":"2","key":"2020011411395412000_B12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/bjh.15256","article-title":"How do we move towards a personalised approach in the treatment of Early Hodgkin lymphoma?","volume":"182","author":"Maraldo","year":"2018","journal-title":"Br J Haematol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/1\/203\/1552625\/advancesadv2019001023.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/1\/203\/1552625\/advancesadv2019001023.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T11:41:34Z","timestamp":1579002094000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/4\/1\/203\/430193\/Maximum-tumor-diameter-is-associated-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,14]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2019001023","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,14]]}}}